Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Stock analysts at William Blair increased their FY2024 EPS estimates for Henry Schein in a research report issued to clients and investors on Tuesday, November 5th. William Blair analyst B. Vazquez now expects that the company will earn $4.78 per share for the year, up from their previous forecast of $4.74. The consensus estimate for Henry Schein’s current full-year earnings is $4.76 per share. William Blair also issued estimates for Henry Schein’s Q2 2025 earnings at $1.30 EPS, Q3 2025 earnings at $1.30 EPS and FY2026 earnings at $5.59 EPS.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS.
Get Our Latest Stock Report on HSIC
Henry Schein Stock Down 2.1 %
Shares of Henry Schein stock opened at $68.00 on Friday. The firm has a market cap of $8.48 billion, a PE ratio of 27.98, a P/E/G ratio of 2.00 and a beta of 0.87. The business’s 50 day simple moving average is $70.51 and its 200 day simple moving average is $69.73. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.42. Henry Schein has a 52-week low of $62.12 and a 52-week high of $82.63.
Insider Buying and Selling
In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.14% of the stock is owned by insiders.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Cromwell Holdings LLC grew its position in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC acquired a new position in Henry Schein in the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the 2nd quarter worth $37,000. Blue Trust Inc. lifted its holdings in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares in the last quarter. 96.62% of the stock is owned by institutional investors.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Investing In Automotive Stocks
- MarketBeat Week in Review – 11/4 – 11/8
- What Does a Stock Split Mean?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.